BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

EZN-2968: Phase I started

Enzon began an open-label Phase I trial to evaluate weekly 8 mg/kg IV EZN-2968 for 3 weeks of a 6-week cycle in 22 patients. Enzon has...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >